<unk>  is an antibiotic medication used for the treatment of multi-drug-resistant tuberculosis affecting the lungs. It is generally used together with bedaquiline and linezolid. It is taken by mouth. The most common side effects include nerve damage, acne, vomiting, headache, low blood sugar, diarrhea, and liver inflammation. It is in the nitroimidazole class of medications.<unk>  was approved for medical use in the United States in August 2019, and in the European Union in July 2020.<unk>  was developed by TB Alliance. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Pretomanid
Vagisil
Tezacaftor
Vorapaxar
Dosulepin
Lipotuck
Sesquimustard
Vosoritide